Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Euro Sings Post-ECB Meeting, Pound Suffers Brexit Blues, Dow Jones Awaits FDA Deci

Published 11/12/2020, 05:32

An ECB afternoon that was free of euro-criticism allowed the currency to make strides this Thursday.

As expected, Christine Lagarde and co. announced a €500 billion expansion of its pandemic emergency purchase programme (PEPP), while keeping its main interest rates unchanged. The central bank also failed to take issue with the euro’s recent gains, something that in and of itself spurred the currency on even further.

Against the dollar the euro climbed half a percent, while against the pound its gains swelled to 1.3%, exploiting an already weakened sterling.

Talking of the pound, the cable was also down 0.8% following news that the UK and EU have set a new end of weekend deadline to reach a Brexit deal.

With sterling under a lot of pressure, the FTSE was able to emerge as the session’s major index winner. Up half a percent, the FTSE re-crossed 6,600 and returned to its recent 9-month highs, all while its Eurozone peers were either flat, in the case of the CAC, or down 0.4%, in the case of the DAX.

Despite US daily covid-19 deaths crossing 3,000 for the first time, the Dow Jones only fell 0.1% this Thursday. And while it did spend the early hours of the open sporadically dipping below 30,000, the index appears to be in something of a holding pattern until the FDA announce their decision of the Pfizer/BioNTech vaccine later today.

It’s going to be interesting to see how much the Dow moves if/when the FDA do give the preparation their approval, since, post-UK deployment and a Canadian thumbs up, such an outcome feels like a forgone conclusion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.